ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2024
|
|
StuTM
|
19 |
5.7K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
19
|
5.7K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2024
|
|
StuTM
|
19 |
5.7K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
19
|
5.7K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2024
|
|
StuTM
|
19 |
5.7K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
19
|
5.7K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2024
|
|
StuTM
|
19 |
5.7K |
18 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
19
|
5.7K
|
18
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
StuTM
|
2.4K |
1.0M |
2 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical receives U.S. FDA clearance for CT LVAS
|
|
StuTM
|
38 |
17K |
10 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
38
|
17K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
StuTM
|
2.4K |
1.0M |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
StuTM
|
2.4K |
1.0M |
20 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
20
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
StuTM
|
2.4K |
1.0M |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
4
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
73
|
34K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
StuTM
|
2.4K |
1.0M |
14 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
14
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
73
|
34K
|
1
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
73
|
34K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
StuTM
|
733 |
324K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
733
|
324K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical reports positive 1H FY2024 results
|
|
StuTM
|
5 |
2.6K |
8 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
5
|
2.6K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Ann: U.S. budget pushes for action on screening for Veterans
|
|
StuTM
|
23 |
9.9K |
12 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
23
|
9.9K
|
12
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
StuTM
|
6.2K |
1.1M |
13 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
6.2K
|
1.1M
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical secures participation in pivotal burn pit research
|
|
StuTM
|
14 |
5.8K |
10 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
14
|
5.8K
|
10
|
|
ASX - By Stock
|
AD8 |
Re:
$30 Party
|
|
StuTM
|
23 |
8.9K |
5 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
23
|
8.9K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs distribution agreement with Blackford
|
|
StuTM
|
49 |
14K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
49
|
14K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Imbio secures research agreement with US Dept of Vet Affairs
|
|
StuTM
|
26 |
7.0K |
13 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
26
|
7.0K
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Imbio secures research agreement with US Dept of Vet Affairs
|
|
StuTM
|
26 |
7.0K |
5 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
26
|
7.0K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical signs distribution agreement with Blackford
|
|
StuTM
|
49 |
14K |
6 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
49
|
14K
|
6
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
2 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
73
|
34K
|
2
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
73
|
34K
|
0
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
73
|
34K
|
0
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
73
|
34K
|
0
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
73
|
34K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
StuTM
|
2.4K |
1.0M |
8 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
8
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
8 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
73
|
34K
|
8
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
2 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
73
|
34K
|
2
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
0 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
73
|
34K
|
0
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
3 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
73
|
34K
|
3
|
|
ASX - By Stock
|
PME |
Re:
Ann: Company Announcement - Interim Results
|
|
StuTM
|
73 |
34K |
10 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
73
|
34K
|
10
|
|
ASX - By Stock
|
PME |
Re:
Ann: PME launches Visage Ease VP for Apple Vision Pro
|
|
StuTM
|
18 |
6.0K |
1 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
18
|
6.0K
|
1
|
|
ASX - By Stock
|
AD8 |
Re:
Ann: Audinate delivers record revenue & EBITDA in 1H24
|
|
StuTM
|
63 |
19K |
2 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
63
|
19K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
StuTM
|
2.4K |
1.0M |
18 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
18
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
StuTM
|
2.4K |
1.0M |
6 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
6
|
|
ASX - By Stock
|
PME |
Re:
Ann: Sale of 1M shares each by founders
|
|
StuTM
|
17 |
9.7K |
2 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
17
|
9.7K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2024
|
|
StuTM
|
34 |
11K |
7 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
34
|
11K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2024
|
|
StuTM
|
34 |
11K |
23 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
34
|
11K
|
23
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
StuTM
|
2.4K |
1.0M |
23 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
2.4K
|
1.0M
|
23
|
|
ASX - By Stock
|
PME |
Re:
Ann: Sale of 1M shares each by founders
|
|
StuTM
|
17 |
9.7K |
1 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
17
|
9.7K
|
1
|
|
ASX - By Stock
|
PME |
Re:
Ann: Sale of 1M shares each by founders
|
|
StuTM
|
17 |
9.7K |
0 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
17
|
9.7K
|
0
|
|
ASX - By Stock
|
PME |
Re:
Ann: PME signs A$20M, 8-year contract with OHSU
|
|
StuTM
|
25 |
14K |
7 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
25
|
14K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical webinar with Dr David Shulkin
|
|
StuTM
|
41 |
15K |
13 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
41
|
15K
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical webinar with Dr David Shulkin
|
|
StuTM
|
41 |
15K |
13 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
41
|
15K
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical webinar with Dr David Shulkin
|
|
StuTM
|
41 |
15K |
12 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
41
|
15K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Ann: U.S. CMS Approves Reimbursement for 4DMedical
|
|
StuTM
|
150 |
67K |
11 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
150
|
67K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
StuTM
|
2.4K |
1.0M |
12 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
2.4K
|
1.0M
|
12
|
|